A study reported that high estrogen receptor downregulated the expression PD-1/PD-L1 in breast cancer, thus leading to the reduction of CD8+T cells infiltrating the tumor by inhibiting the IL-17 signal transduction (38). Here, CD8A is linked to neoplasm.